Options
經尿道攝護腺切除術對良性攝護腺肥大患者交感迷走神經平衡與下泌尿道症狀之影響
Date Issued
2026
Author(s)
陳冠宇
CHEN, KUAN-YU
Advisor
Abstract
研究目的:良性攝護腺肥大 (Benign prostate hyperplasia, BPH) 所引起的下尿路症狀 (Lower urinary tract symptoms, LUTS) 會嚴重損害患者的生活品質。經尿道攝護腺切除術 (Transurethral resection of the prostate, TURP) 目前被視為治療膀胱出口阻塞 (Bladder outlet obstruction, BOO) 的黃金標準手術。然而,TURP對自主神經系統 (Autonomic nervous system, ANS) 功能,特別是透過心率變異度 (Heart rate variability, HRV) 評估的影響,過去較少被深入探討。本研究旨在釐清TURP術後自主神經功能的變化,並將HRV與特定的LUTS領域進行相關性分析研究方法及資料:本研究採前瞻性觀察性世代研究,納入2018年至2024年間於醫學中心接受TURP的242位BPH患者。入選標準為年齡≧50歲、國際攝護腺症狀評分 (International Prostate Symptom Score, IPSS) ≧8且有BOO證據之患者。研究於術前及術後3個月進行評估,測量指標包含HRV (Standard deviation of normal-to normal intervals, SDNN; Low-frequency/ High-frequency ratio, LF/HF) 、IPSS評分 (包含排尿與儲尿子分數) 及生活品質指標。統計分析採用成對t檢定與多變量線性回歸分析,並校正年齡、BMI及攝護腺體積等變因。研究結果:患者術後的HRV (SDNN) 從36.97 ± 22.80ms顯著提升至51.67 ± 27.59ms (p=0.032)。代表自主神經平衡的LF/HF比值從1.63 ± 1.60降至0.73 ± 0.52 (p=0.028),顯示術後副交感神經活性增加。在症狀改善方面,IPSS總分從18.5 ± 6.2降至8.3 ± 4.1 (p<0.001),QoL亦從3.5 ± 1.2改善至1.8 ± 0.9 (p=0.003)。亞族群分析顯示,高齡患者 (≧65歲) 與攝護腺體積較大 (≧50 mL) 的患者在術後的自主神經調控及排尿症狀上有更顯著的改善。此外,HRV與IPSS排尿子分數呈現顯著負相關 (r=-0.42, p=0.012)。結論:經尿道攝護腺切除術 (TURP) 能改善BPH患者的下尿路症狀、生活品質,並與提升自主神經系統功能正向相關。HRV與症狀程度的相關性,使其具有作為評估LUTS嚴重程度與監測治療反應之非侵入性生物標記的潛力。未來仍需長期的縱向研究來驗證其對心血管健康的長期預後價值。
Objective: Benign Prostatic Hyperplasia (BPH) causes Lower Urinary Tract Symptoms (LUTS) , impairing quality of life (QoL) . Transurethral Resection of the Prostate (TURP) is the gold-standard surgical treatment for Bladder Outlet Obstruction (BOO) , but its effects on Autonomic Nervous System (ANS) function—assessed via Heart Rate Variability (HRV) —remain underexplored. To our knowledge, this is the first study to correlate HRV with specific LUTS domains pre- and post-TURP, establishing HRV as a potential biomarker for BPH management.Methods and Materials: In a prospective study, 242 men with BPH underwent TURP (2018–2024) . Inclusion required age ≥ 50 years, International Prostate Symptom Score (IPSS) ≥ 8, and BOO evidence. HRV (Standard Deviation of Normal-to-Normal Intervals [SDNN], Low-Frequency/High-Frequency [LF/HF] ratio) , IPSS, and QoL were assessed preoperatively and 3 months postoperatively. Paired t-tests, Pearson correlations, and multivariate regression (adjusted for age, Body Mass Index [BMI], prostate volume) were used (p < 0.05) . Results:HRV (SDNN) increased from 36.97 ± 22.80 ms to 51.67 ± 27.59 ms (p = 0.032) , and LF/HF ratio decreased from 1.63 ± 1.60 to 0.73 ± 0.52 (p = 0.028) . IPSS fell from 18.5 ± 6.2 to 8.3 ± 4.1 (p < 0.001) , with improved voiding (p = 0.004) and storage (p = 0.002) subscores. QoL improved from 3.5 ± 1.2 to 1.8 ± 0.9 (p = 0.003) . HRV correlated inversely with IPSS voiding (r =−0.42, p = 0.012; r =−0.38, p = 0.019 post-TURP) and storage subscores (r =−0.29, p = 0.045) . Older patients (≥65 years) and those with larger prostates (≥50 mL) showed greater improvements. Conclusion: TURP enhances LUTS, QoL, and ANS function. HRV’s correlation with LUTS suggests its biomarker potential, with possible cardiovascular benefits. Longitudinal studies are needed.
Subjects
良性攝護腺肥大
下尿路症狀
經尿道攝護腺切除術
心率變異度
自主神經系統
benign prostatic hyperplasia
lower urinary tract symptoms
transurethral resection of the prostate
heart rate variability
autonomic nervous system
Type
thesis
File(s)
No Thumbnail Available
Name
114CSMU0534011-001.pdf
Size
1.26 MB
Format
Adobe PDF
Checksum
(MD5):9459cc0067da826f106919c6bad55b0b